No­vo Nordisk makes the case it’s more than We­govy in new cor­po­rate ad cam­paign

While so­cial me­dia is abuzz wit­th No­vo Nordisk’s di­a­betes and obe­si­ty med­i­cines Ozem­pic and We­govy, it’s prob­a­bly safe to say far few­er Tik­Tok­ers and In­sta­gram­mers …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.